Tech Company Financing Transactions

Anchor Therapeutics Funding Round

On 6/30/2009, Anchor Therapeutics received $10 million in funding from HealthCare Ventures, Novartis Venture Fund and TVM Capital.

Transaction Overview

Announced On
6/30/2009
Transaction Type
Venture Equity
Amount
$10,000,000
Round
Undisclosed
Investors

HealthCare Ventures (Christopher Mirabelli)

Novartis Venture Fund (Lauren Silverman)

TVM Capital (Jens Eckstein)

Proceeds Purpose
Proceeds purposes were not disclosed.

Company Information

Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
67 Rogers St. Bldg 600 - 6201
Cambridge, MA 02142
USA
Email Address
Overview
Anchor Therapeutics develops pharmaceutical candidates to address cancer, inflammation, metabolism, heart disease, and pain.
Profile
Anchor Therapeutics LinkedIn Company Profile
Social Media
Anchor Therapeutics Company Twitter Account
Company News
Anchor Therapeutics News
Facebook
Anchor Therapeutics on Facebook
YouTube
Anchor Therapeutics on YouTube

Management Team

Title
Name
Email & Social
Chief Scientific Officer
Stephen Hunt
  Stephen Hunt LinkedIn Profile  Stephen Hunt Twitter Account  Stephen Hunt News  Stephen Hunt on Facebook
President
Thomas McMurry
  Thomas McMurry LinkedIn Profile  Thomas McMurry Twitter Account  Thomas McMurry News  Thomas McMurry on Facebook


 

 

Browse more venture capital transactions:

Prev: 6/30/2009: Biofisica venture capital transaction
Next: 6/30/2009: Cebix venture capital transaction

 

Share this article

 


About Our Venture Capital Transactions Database

We do our best to report on every notable VC transaction. VC investment data records reported here are sourced from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary